Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Glecirasib by Jacobio Pharmaceuticals Group for Gastric Cancer: Likelihood of Approval
Glecirasib is under clinical development by Jacobio Pharmaceuticals Group and currently in Phase II for Gastric Cancer. According to GlobalData,...
Glecirasib by Jacobio Pharmaceuticals Group for Metastatic Pancreatic Cancer: Likelihood of Approval
Glecirasib is under clinical development by Jacobio Pharmaceuticals Group and currently in Phase II for Metastatic Pancreatic Cancer. According to...
Glecirasib by Jacobio Pharmaceuticals Group for Biliary Tumor: Likelihood of Approval
Glecirasib is under clinical development by Jacobio Pharmaceuticals Group and currently in Phase II for Biliary Tumor. According to GlobalData,...
Glecirasib by Jacobio Pharmaceuticals Group for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
Glecirasib is under clinical development by Jacobio Pharmaceuticals Group and currently in Phase II for Pancreatic Ductal Adenocarcinoma. According to...